trial · primary record
Gemcitabine
Leiomyosarcoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2031-02-01 |
| Primary endpoint | Safety and adverse events (AEs) |
| Registry ID | NCT06308419 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:38.095Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06308419
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.